Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the ...

The global systemic mastocytosis market is witnessing robust growth, driven by increased prevalence of KIT gene mutations and advancements in targeted therapies like avapritinib and bezuclastinib.

A Columbus family is on a mission to find a cure for a rare genetic disorder. Saturday morning was their third annual Hope With Lo 5K. “We believe that hope isn’t a feeling that it’s a force. We’ve ...

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found ...

The ACR recently issued the first formal international consensus guidance statement on diagnosing and managing VEXAS syndrome.

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments.

EXCLUSIVE: Analysis by a charity shows almost 35,000 lives have been saved by advances in treating childhood cancer since the 1970s.

Correctly distinguishing between look-alike tumors found in the brain during surgery can guide critical decisions in real time while ...

Alexis Tappan poses for a portrait with her mother and father at Methodist Le Bonheur Hospital. Memphis, Tenn., Thursday, ...

The new therapy is being hailed as a breakthrough. But the small study has some limitations – and hasn’t been peer-reviewed.

Working with agency partner DCX Growth Accelerator, GeneDX takes direct aim at the issue of underdiagnosis of pediatric rare diseases.